SCHEMBL6359858

SCHEMBL6359858

Cc1ccc(Nc2cc(N3CCN(c4ncccn4)CC3)nc([C@@]3(C)CNC[C@@H](C)O3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GALR1 P47211 5/20 0.40
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
GALR2 O43603 4/20 0.35
GBA1 P04062 1/20 0.35
BPTF Q12830 1/20 0.35
BLM P54132 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
ROCK1 Q13464 1/20 0.33
AURKA O14965 1/20 0.33
KCNH2 Q12809 1/20 0.33
CACNA1C Q13936 1/20 0.33
ASIC3 Q9UHC3 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6359862 1.00 GALR1 (0.40) GALR1LMNAMAPTGALR2GBA1
SCHEMBL6359861 0.75 MAPT (0.48) GALR1LMNAMAPTGALR2GBA1
SCHEMBL3240588 0.72 GALR2 (0.59) GALR1LMNAMAPTGALR2GBA1
SCHEMBL6359088 0.66 ROCK2 (0.35)
SCHEMBL3241392 0.66 GALR2 (0.59) GALR1LMNAMAPTGALR2SMN1; SMN2
SCHEMBL3240980 0.64 GALR2 (0.62) GALR1LMNAMAPTGALR2
SCHEMBL18153416 0.64 CASP1 (0.61) GALR1LMNAMAPTGALR2BPTF
SCHEMBL3245932 0.64 GALR2 (0.61) GALR1LMNAMAPTGALR2GBA1
SCHEMBL18153355 0.63 LMNA (0.69) GALR1LMNAMAPTGALR2BPTF
SCHEMBL3246321 0.63 CASP1 (0.59) GALR1LMNAMAPTGALR2BPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936607-B2 2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety H. LUNOBECK A/S (DK) 2005-08-30 US disclosed